Global Clobazam API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Clobazam API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Clobazam API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Clobazam Tablets
- 1.4.3 Others
- 1.5 Global Clobazam API Market Size & Forecast
- 1.5.1 Global Clobazam API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Clobazam API Sales Quantity (2020-2031)
- 1.5.3 Global Clobazam API Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Piramal Enterprises Limited
- 2.1.1 Piramal Enterprises Limited Details
- 2.1.2 Piramal Enterprises Limited Major Business
- 2.1.3 Piramal Enterprises Limited Clobazam API Product and Services
- 2.1.4 Piramal Enterprises Limited Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Piramal Enterprises Limited Recent Developments/Updates
- 2.2 Sanofi
- 2.2.1 Sanofi Details
- 2.2.2 Sanofi Major Business
- 2.2.3 Sanofi Clobazam API Product and Services
- 2.2.4 Sanofi Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Sanofi Recent Developments/Updates
- 2.3 Cambrex Corporation
- 2.3.1 Cambrex Corporation Details
- 2.3.2 Cambrex Corporation Major Business
- 2.3.3 Cambrex Corporation Clobazam API Product and Services
- 2.3.4 Cambrex Corporation Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Cambrex Corporation Recent Developments/Updates
- 2.4 Centaur Pharmaceuticals
- 2.4.1 Centaur Pharmaceuticals Details
- 2.4.2 Centaur Pharmaceuticals Major Business
- 2.4.3 Centaur Pharmaceuticals Clobazam API Product and Services
- 2.4.4 Centaur Pharmaceuticals Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Centaur Pharmaceuticals Recent Developments/Updates
- 2.5 Amneal Pharmaceuticals, Inc.
- 2.5.1 Amneal Pharmaceuticals, Inc. Details
- 2.5.2 Amneal Pharmaceuticals, Inc. Major Business
- 2.5.3 Amneal Pharmaceuticals, Inc. Clobazam API Product and Services
- 2.5.4 Amneal Pharmaceuticals, Inc. Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Amneal Pharmaceuticals, Inc. Recent Developments/Updates
- 2.6 F.I.S. Fabbrica Italiana Sintetici
- 2.6.1 F.I.S. Fabbrica Italiana Sintetici Details
- 2.6.2 F.I.S. Fabbrica Italiana Sintetici Major Business
- 2.6.3 F.I.S. Fabbrica Italiana Sintetici Clobazam API Product and Services
- 2.6.4 F.I.S. Fabbrica Italiana Sintetici Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 F.I.S. Fabbrica Italiana Sintetici Recent Developments/Updates
- 2.7 Lake Chemicals Pvt. Ltd.
- 2.7.1 Lake Chemicals Pvt. Ltd. Details
- 2.7.2 Lake Chemicals Pvt. Ltd. Major Business
- 2.7.3 Lake Chemicals Pvt. Ltd. Clobazam API Product and Services
- 2.7.4 Lake Chemicals Pvt. Ltd. Clobazam API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Lake Chemicals Pvt. Ltd. Recent Developments/Updates
3 Competitive Environment: Clobazam API by Manufacturer
- 3.1 Global Clobazam API Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Clobazam API Revenue by Manufacturer (2020-2025)
- 3.3 Global Clobazam API Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Clobazam API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Clobazam API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Clobazam API Manufacturer Market Share in 2024
- 3.5 Clobazam API Market: Overall Company Footprint Analysis
- 3.5.1 Clobazam API Market: Region Footprint
- 3.5.2 Clobazam API Market: Company Product Type Footprint
- 3.5.3 Clobazam API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Clobazam API Market Size by Region
- 4.1.1 Global Clobazam API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Clobazam API Consumption Value by Region (2020-2031)
- 4.1.3 Global Clobazam API Average Price by Region (2020-2031)
- 4.2 North America Clobazam API Consumption Value (2020-2031)
- 4.3 Europe Clobazam API Consumption Value (2020-2031)
- 4.4 Asia-Pacific Clobazam API Consumption Value (2020-2031)
- 4.5 South America Clobazam API Consumption Value (2020-2031)
- 4.6 Middle East & Africa Clobazam API Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Clobazam API Sales Quantity by Type (2020-2031)
- 5.2 Global Clobazam API Consumption Value by Type (2020-2031)
- 5.3 Global Clobazam API Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Clobazam API Sales Quantity by Application (2020-2031)
- 6.2 Global Clobazam API Consumption Value by Application (2020-2031)
- 6.3 Global Clobazam API Average Price by Application (2020-2031)
7 North America
- 7.1 North America Clobazam API Sales Quantity by Type (2020-2031)
- 7.2 North America Clobazam API Sales Quantity by Application (2020-2031)
- 7.3 North America Clobazam API Market Size by Country
- 7.3.1 North America Clobazam API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Clobazam API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Clobazam API Sales Quantity by Type (2020-2031)
- 8.2 Europe Clobazam API Sales Quantity by Application (2020-2031)
- 8.3 Europe Clobazam API Market Size by Country
- 8.3.1 Europe Clobazam API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Clobazam API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Clobazam API Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Clobazam API Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Clobazam API Market Size by Region
- 9.3.1 Asia-Pacific Clobazam API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Clobazam API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Clobazam API Sales Quantity by Type (2020-2031)
- 10.2 South America Clobazam API Sales Quantity by Application (2020-2031)
- 10.3 South America Clobazam API Market Size by Country
- 10.3.1 South America Clobazam API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Clobazam API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Clobazam API Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Clobazam API Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Clobazam API Market Size by Country
- 11.3.1 Middle East & Africa Clobazam API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Clobazam API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Clobazam API Market Drivers
- 12.2 Clobazam API Market Restraints
- 12.3 Clobazam API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Clobazam API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Clobazam API
- 13.3 Clobazam API Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Clobazam API Typical Distributors
- 14.3 Clobazam API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Clobazam API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Clobazam is a 1,5-benzodiazepine and partial gamma-aminobutyric acid (GABA) receptor agonist, with anxiolytic, sedative, and anticonvulsant activities. Clobazam binds to a specific site, distinct from the inhibitory neurotransmitter GABA binding site, on the benzodiazepine-GABA-A-chloride ionophore receptor complex located in the central nervous system (CNS). This binding causes an allosteric modification of the receptor and enhances the affinity of GABA to the receptor leading to an increase in the opening of chloride-channels. This leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential and a decrease in neuronal excitability.
This report is a detailed and comprehensive analysis for global Clobazam API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Clobazam API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Clobazam API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Clobazam API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Clobazam API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clobazam API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clobazam API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Piramal Enterprises Limited, Sanofi, Cambrex Corporation, Centaur Pharmaceuticals, Amneal Pharmaceuticals, Inc., F.I.S. Fabbrica Italiana Sintetici, Lake Chemicals Pvt. Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Clobazam API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Clobazam Tablets
Others
Major players covered
Piramal Enterprises Limited
Sanofi
Cambrex Corporation
Centaur Pharmaceuticals
Amneal Pharmaceuticals, Inc.
F.I.S. Fabbrica Italiana Sintetici
Lake Chemicals Pvt. Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Clobazam API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Clobazam API, with price, sales quantity, revenue, and global market share of Clobazam API from 2020 to 2025.
Chapter 3, the Clobazam API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Clobazam API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Clobazam API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Clobazam API.
Chapter 14 and 15, to describe Clobazam API sales channel, distributors, customers, research findings and conclusion.